Acro Biomedical (ACBM) Cash & Current Investments (2015 - 2025)
Acro Biomedical's quarterly Cash & Current Investments came in at $4098.0 in Q4 2025, up 760.92% year-on-year from $476.0 in Q4 2024, and down 5.2% quarter-over-quarter from $4323.0 in Q3 2025.
Acro Biomedical has reported Cash & Current Investments for 11 years, with the latest figure at $4098.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash & Current Investments rose 760.92% year-over-year to $4098.0; the trailing twelve-month figure through Dec 2025 stood at $4098.0 (up 760.92% YoY), and the FY2025 full-year result was $4098.0, up 760.92% from the prior year.
- Cash & Current Investments for Q4 2025 stood at $4098.0, down from $4323.0 in the prior quarter.
- The five-year high for Cash & Current Investments was $357668.0 in Q1 2022, with the low at $26.0 in Q2 2025.
- Average Cash & Current Investments over 5 years is $45593.5, with a median of $5202.0 recorded in 2022.
- Year-over-year, Cash & Current Investments soared 99042.95% in 2021 and plunged 98.73% in 2023.
- Tracing ACBM's Cash & Current Investments over 5 years: stood at $95248.0 in 2021, then slumped by 93.86% to $5852.0 in 2022, then plunged by 93.57% to $376.0 in 2023, then rose by 26.6% to $476.0 in 2024, then soared by 760.92% to $4098.0 in 2025.
- The last three Cash & Current Investments figures came in at $4098.0 (Q4 2025), $4323.0 (Q3 2025), and $26.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 1.00 |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | 4,098.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,098.00 |
| Sep 30, 2025 | 4,323.00 |
| Jun 30, 2025 | 26.00 |
| Mar 31, 2025 | 251.00 |
| Dec 31, 2024 | 476.00 |
| Sep 30, 2024 | 701.00 |
| Jun 30, 2024 | 926.00 |
| Mar 31, 2024 | 151.00 |
| Dec 31, 2023 | 376.00 |
| Sep 30, 2023 | 7,501.00 |
| Jun 30, 2023 | 6,910.00 |
| Mar 31, 2023 | 4,552.00 |
| Dec 31, 2022 | 5,852.00 |
| Sep 30, 2022 | 16,188.00 |
| Jun 30, 2022 | 12,107.00 |
| Mar 31, 2022 | 357,668.00 |
| Dec 31, 2021 | 95,248.00 |
| Sep 30, 2021 | 154,663.00 |
| Jun 30, 2021 | 215,494.00 |
| Mar 31, 2021 | 24,359.00 |
| Dec 30, 2020 | 18,123.00 |
| Sep 30, 2020 | 156.00 |
| Jun 30, 2020 | 381.00 |
| Mar 31, 2020 | 10,636.00 |
| Dec 31, 2019 | 911.00 |
| Sep 30, 2019 | 6,464.00 |
| Jun 30, 2019 | 5,223.00 |
| Mar 31, 2019 | 5,404.00 |
| Dec 31, 2018 | 42,599.00 |
| Sep 30, 2018 | 1,148.00 |
| Jun 30, 2018 | 4,615.00 |
| Mar 31, 2018 | 471,831.00 |
| Dec 31, 2017 | 8,542.00 |
| Sep 30, 2017 | 36,810.00 |
| Dec 31, 2016 | 2,391.00 |
| Sep 30, 2016 | 2,533.00 |
| Jun 30, 2016 | 2,141.00 |
| Mar 31, 2016 | 7,742.00 |
| Dec 31, 2015 | 15,907.00 |
| Sep 30, 2015 | 27,275.00 |